The addition of inflammatory markers to cardiovascular risk assessments is critical. Here to walk us through how we can better define patients at risk using this multi-marker approach beyond lipids are Drs. Atul Sachdev and Erminia Guarneri, hosted by Dr. Michael Roizen.